To include your compound in the COVID-19 Resource Center, submit it here.

FDA approves Pfizer's Sutent for adjuvant RCC

FDA approved Sutent sunitinib from Pfizer Inc. (NYSE:PFE) as adjuvant treatment of patients

Read the full 139 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE